The American Medical Association yesterday announced Current Procedural Terminology codes for reporting the two-dose Novavax COVID-19 vaccine and its administration on medical claims if the Food and Drug Administration approves the candidate vaccine or authorizes it for emergency use. Creating unique procedural codes for each authorized COVID-19 vaccine helps providers accurately manage patient immunizations.

Related News Articles

Headline
The Health Resources and Services Administration today awarded 14 organizations grants to hire people to support COVID-19 vaccination and outreach in…
Headline
The Food and Drug Administration Friday authorized for emergency use two batches of drug substance manufactured for the Janssen (Johnson & Johnson)…
Headline
Novavax today announced phase 3 trial results for its COVID-19 vaccine, saying it provides 100% protection against moderate and severe disease, with a 90.…
Headline
The Centers for Disease Control and Prevention is asking jurisdictions to distribute portions of their COVID-19 vaccine allocations to enable administration at…
Headline
Johnson & Johnson today said the Food and Drug Administration agreed to extend the expiration date for its COVID-19 vaccine by six weeks. The move means…
Headline
During the COVID-19 pandemic, Grand Rapids, Mich-based Spectrum Health used the full scope of its resources to enable easy vaccine access, keep its communities…